← Back to Search

Colorectal Cancer Screening Program for Colorectal Cancer

N/A
Recruiting
Led By Roshan Bastani
Research Sponsored by Jonsson Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PATIENTS: 50-75 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Summary

This trial aims to increase CRC screening rates in minority & low-income groups with a tailored program & FIT test to detect signs of CRC sooner.

Who is the study for?
This trial is for low-income and ethnic minority individuals aged 50-75 who have visited a clinic at least once in the past two years. It aims to increase colorectal cancer screening rates within these groups.
What is being tested?
The study tests a culturally-tailored program that includes educational interventions, text message reminders, feedback, and fecal immunochemical testing (FIT) to improve colorectal cancer screening among eligible patients.
What are the potential side effects?
Since this trial focuses on education and screening rather than medication or invasive procedures, there are no direct side effects from the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Colorectal cancer (CRC) screening rate
Rate of failure to provide a FIT kit to an eligible patient making a clinic visit
Return rate of completed FIT kits

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (education, feedback, consult, FIT kit, text message)Experimental Treatment8 Interventions
Physicians and clinic staff receive ongoing training, education, and feedback on CRC screening, and utilize point-of-care clinical decision support tool throughout the trial. Patients receive CRC screening recommendations from provider, a FIT kit with culturally tailored instructions, consultation with clinic staff, and text message reminders throughout the trial.
Group II: Arm II (usual care)Active Control2 Interventions
Physicians and clinic staff provide and patients recieve CRC screening usual care throughout the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010
Feedback
2018
N/A
~18170

Find a Location

Who is running the clinical trial?

Jonsson Comprehensive Cancer CenterLead Sponsor
369 Previous Clinical Trials
25,429 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
16,614 Total Patients Enrolled
Roshan BastaniPrincipal InvestigatorUCLA / Jonsson Comprehensive Cancer Center
~67 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top